Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Shares Outstanding (2022 - 2025)

Atara Biotherapeutics' Shares Outstanding history spans 4 years, with the latest figure at $7.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 25.0% year-over-year to $7.3 million; the TTM value through Dec 2025 reached $7.3 million, up 25.0%, while the annual FY2025 figure was $7.3 million, 25.0% up from the prior year.
  • Shares Outstanding reached $7.3 million in Q4 2025 per ATRA's latest filing, up from $7.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $7.3 million in Q4 2025 to a low of $93406.0 in Q1 2022.
  • Average Shares Outstanding over 4 years is $4.3 million, with a median of $4.5 million recorded in 2023.
  • The largest YoY upside for Shares Outstanding was 4197.05% in 2023 against a maximum downside of 10.97% in 2023.
  • A 4-year view of Shares Outstanding shows it stood at $3.8 million in 2022, then grew by 10.97% to $4.3 million in 2023, then soared by 37.6% to $5.9 million in 2024, then increased by 25.0% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for ATRA's Shares Outstanding are $7.3 million (Q4 2025), $7.2 million (Q3 2025), and $7.0 million (Q2 2025).